Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in Coronavirus disease 2019
Gallery

COVID-19

,

Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in Coronavirus disease 2019

,
2021-03-11T18:42:01-07:00

Sweeney, T. et al. Critical Care Medicine. Feb 2021.

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
Gallery

COVID-19

, , ,

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

, , ,
2021-03-11T18:43:56-07:00

Thair, S. et al. Science Direct. Dec 2020.

A 6-mRNA host response using patients with non-COVID-19 infections accurately predicts severity of COVID-19
Gallery

COVID-19

, ,

A 6-mRNA host response using patients with non-COVID-19 infections accurately predicts severity of COVID-19

, ,
2021-03-12T12:53:07-07:00

Buturovic, L. et. al. medRxiv, Dec. 2020.

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
Gallery

COVID-19

, ,

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

, ,
2021-03-11T18:45:53-07:00

Thair SA, et al. medRxiv 2020.06.18.20131326.

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis. All products are in development and are not FDA cleared.

We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page.

Go to Top